ENTECAVIR

作品数：130被引量：879H指数：17
导出分析报告
相关领域：医药卫生更多>>
相关作者：朱映光温钦清丁莹刘萍萍廖娟更多>>
相关机构：华东师范大学北京化工大学四川大学华西医院浙江金立源药业有限公司更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划广西壮族自治区自然科学基金福建省自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=World Journal of Clinical Casesx
共 条 记 录，以下是1-3
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir
《World Journal of Clinical Cases》2023年第34期8139-8146,共8页Gui-Cai Yuan Ai-Zhen Chen Wei-Xin Wang Xu-Lan Yi Long Tu Fang Peng Zhi-Hong Qiu 
Study on the efficacy and safety of tenofovir alafenamide in treating chronic hepatitis B patients with poor entecavir response,No.SKJP22020201008.
BACKGROUND Entecavir(ETV)is a potent and safe antiviral agent for patients with chronic hepatitis B(CHB);however,some patients may exhibit suboptimal response or resistance to ETV.Tenofovir alafenamide(TAF)is a novel ...
关键词：ENTECAVIR Tenofovir alafenamide Chronic hepatitis B Virologic response Renal and bone toxicity Suboptimal response 
One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or C
《World Journal of Clinical Cases》2022年第28期10085-10096,共12页Jing-Hang Xu Sa Wang Da-Zhi Zhang Yan-Yan Yu Chong-Wen Si Zheng Zeng Zhong-Nan Xu Jun Li Qing Mao Hong Tang Ji-Fang Sheng Xin-Yue Chen Qin Ning Guang-Feng Shi Qing Xie Xi-Quan Zhang Jun Dai 
BACKGROUND Entecavir(ETV)is a potent and selective nucleotide analog with significant activity against hepatitis B virus(HBV).ETV maleate is a derivative compound of ETV and was reported to have an efficacy and safety...
关键词：Chronic hepatitis B Entecavir maleate Randomized controlled trial Treatment outcome MUTATION GENOTYPE 
Clinical cure and liver fibrosis reversal after postoperative antiviral combination therapy in hepatitis B-associated non-cirrhotic hepatocellular carcinoma: A case report被引量：2
《World Journal of Clinical Cases》2021年第3期714-721,共8页Xue-Ping Yu Qi Lin Zhi-Peng Huang Wei-Shan Chen Ming-Hui Zheng Yi-Juan Zheng Ju-Lan Li Zhi-Jun Su 
Natural Science Foundation of Fujian Province,No.2019J01593;High-Level Talent Innovation Project of Quanzhou,No.2018C067R;Science and Technology Innovation Joint Project of Fujian Province,No.2019Y9048;Youth Research Project of Fujian Provincial Health Commission,No.2018-1-94 and No.2018-1-95;Science and Technology Project of Quanzhou,No.2018Z074 and No.2018Z069.
BACKGROUND The incidence of hepatocellular carcinoma(HCC)is high in China,and approximately 15%-20%of HCC cases occur in the absence of cirrhosis.Compared with patients with cirrhotic HCC,those with non-cirrhotic HCC ...
关键词：Hepatocellular carcinoma Hepatitis B virus ENTECAVIR Pegylated interferon alfa-2b Clinical cure Case report 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部